Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

CMS Ushers In Draft Guidance For Second Drug Price Negotiation Cycle

New guidance released Friday (May 3) on how CMS plans to carry out the next round of its historic drug price negotiation program in Medicare includes a handful of new requirements for how drug makers and various Part D drug dispensing entities must interact to ensure the new maximum fair price (MFP) of a selected drug is made available in 2026 and 2027.

Inside Drug Pricing Home Page


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.